The course of Chronic Inflammatory Demyelinating Polyneuropathy varies greatly between individuals. Some people may experience a bout of CIDP followed by spontaneous recovery, whereas others may experience multiple bouts with partial recovery in between relapses. The disease is a treatable cause of acquired neuropathy, and it is recommended that treatment begin as soon as possible to prevent nerve axon loss. However, some people experience residual numbness or weakness. Corticosteroids, such as prednisone, are used to treat Chronic Inflammatory Demyelinating Polyneuropathy Treatment and may be prescribed alone or in combination with immunosuppressive drugs. Plasma exchange and intravenous immunoglobulin (IVIg) therapy are both effective. IVIg can even be used as a first-line therapy. Physiotherapy may improve muscle strength, function, and mobility, as well as reduce muscle and tendon shrinkage and joint distortions. Read More- https://cmiblogdailydose.blogspot.com/2022/09/chronic-inflammatory-demyelinating.html
0 Comments
Leave a Reply. |
Categories
All
|